市场调查报告书
商品编码
1529748
癫痫监测设备市场规模、份额、趋势分析报告:按产品、最终用途、按地区、细分市场预测,2024-2030 年Epilepsy Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Wearable Devices, Conventional Devices), By End-use (Neurology Centers, Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030 |
癫痫监测设备的市场趋势
2023年全球癫痫监测设备市场规模预估为5.59亿美元,预估2024年至2030年复合年增长率为6.6%。该市场受到多种因素的推动,例如癫痫盛行率的增加、技术进步、门诊监测需求的增加、穿戴式装置的使用增加以及政府倡议的增加。
此外,对改善诊断和治疗的需求不断增加、市场竞争加剧以及远端医疗的重要性日益增加也是推动市场成长的关键因素。全世界范围内癫痫的盛行率正在增加,全世界有相当多的人受到影响。
据世界卫生组织 (WHO) 称,癫痫是一种神经系统疾病,影响全球约 5,000 万人,使其成为全球最常见的慢性疾病之一。根据该报告,大约 80% 的癫痫患者生活在低收入和中等收入国家 (LMIC),这些国家获得优质医疗保健的机会往往有限。癫痫的特征是反覆发作,严重影响患者的生活品质。癫痫的有效诊断和治疗需要先进的监测设备来即时检测和追踪癫痫发作。
光是在美国,估计就有超过 300 万人患有癫痫症。此外,根据美国疾病管制与预防中心的数据,到 2021 年,约有 290 万 18 岁及以上的美国成年人报告患有活动性癫痫。
穿戴式科技和资料分析的进步彻底改变了癫痫监测设备领域。采用配备癫痫侦测演算法的智慧型手錶和健身追踪器,可连续监测患者的生理资料,包括心率、运动和皮肤电活动。这使得能够即时检测潜在的癫痫发作,为患者和医疗保健提供者提供及时、准确的信息,以便做出有关治疗和管理的明智决策。例如,2024年2月,连续、非侵入性、不引人注目的神经系统疾病监测先驱Empatica Inc.宣布推出EpiMonitor。这款穿戴式癫痫监测解决方案的最新创新专为成人和 6 岁及以上儿童设计,采用最尖端科技,为癫痫检测和管理提供无与伦比的便利性和准确性。
此外,政府加强对癫痫研究的资助和投资等措施预计也将在预测期内促进市场成长。例如,英国癫痫研究所宣布,英国政府已透过医学研究慈善机构早期职业研究人员支持基金向英国癫痫研究所投入超过 189 万美元的津贴。该慈善机构在 2022-23 年收到了 135 万美元,在 2021-22 年收到了 562,010.5 美元。此外,2024年3月,英国癫痫协会宣布将投资4,866万美元用于癌症、失智症和癫痫的研究。
癫痫监测设备全球市场细分报告
该报告预测了全球、区域和国家层面的收益成长,并提供了2018年至2030年各子区隔的最新行业趋势分析。在这项研究中,Grand View Research, Inc. 根据产品、最终用途和地区对全球癫痫监测设备市场报告进行了细分。
Epilepsy Monitoring Devices Market Trends
The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives.
Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide.
Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where access to quality healthcare is often limited. The condition is characterized by recurring seizures, which can have a significant impact on a person's quality of life. Effective diagnosis and treatment of epilepsy require advanced monitoring devices that can detect and track seizures in real-time.
In the U.S. alone, over 3 million individuals are estimated to be living with epilepsy. Further, in 2021, about 2.9 million U.S. adults 18 and older reported having active epilepsy, as per the U.S. Centers for Disease Control and Prevention.
The advancement of wearable technology and data analytics has revolutionized the field of epilepsy monitoring devices. The introduction of smartwatches and fitness trackers equipped with seizure detection algorithms has enabled the continuous monitoring of a patient's physiological data, including heart rate, movement, and electrodermal activity. This allows for detecting potential seizure episodes in real-time, providing patients and healthcare providers with timely and accurate information to make informed decisions about treatment and management. For instance, in February 2024, Empatica Inc., a pioneering company in continuous, non-invasive, and discreet monitoring for neurological conditions, announced the launch of EpiMonitor. This latest innovation in wearable epilepsy monitoring solutions is designed for adults and children aged 6 and above, offering cutting-edge technology that provides unparalleled convenience and accuracy in detecting and managing seizures.
Furthermore, growing government initiatives such as funding and investments for epilepsy research are expected to fuel the market's growth over the forecast period. For instance, Epilepsy Research Institute UK announced that the UK government has invested over USD 1.89 million in grant funding into Epilepsy Research UK through its Medical Research Charities Early Career Researchers Support Fund. The charity received USD 1.35 million in 2022-23 and USD 562,010.5 in 2021-22. Further, in March 2024, the British Epilepsy Association announced a USD 48.66 million investment into research for cancer, dementia, and epilepsy.
Global Epilepsy Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global epilepsy monitoring devices market report based on product, end-use, and region:
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
List of Figure
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Epilepsy monitoring devices market: market outlook
Fig. 14 Epilepsy monitoring devices competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Epilepsy monitoring devices market driver impact
Fig. 20 Epilepsy monitoring devices market restraint impact
Fig. 21 Epilepsy monitoring devices market strategic initiatives analysis
Fig. 22 Epilepsy monitoring devices market: Product movement analysis
Fig. 23 Epilepsy monitoring devices market: Product outlook and key takeaways
Fig. 24 Wearable devices market estimates and forecast, 2018 - 2030
Fig. 25 Conventional devices market estimates and forecast, 2018 - 2030
Fig. 26 Epilepsy monitoring devices market: End use movement analysis
Fig. 27 Epilepsy monitoring devices market: End use outlook and key takeaways
Fig. 28 Hospitals & clinics market estimates and forecasts,2018 - 2030
Fig. 29 Ambulatory surgical centers market estimates and forecasts,2018 - 2030
Fig. 30 Neurology centers market estimates and forecasts,2018 - 2030
Fig. 31 Diagnostic centers market estimates and forecasts, 2018 - 2030
Fig. 32 Global Epilepsy monitoring devices market: Regional movement analysis
Fig. 33 Global Epilepsy monitoring devices market: Regional outlook and key takeaways
Fig. 34 Global Epilepsy monitoring devices market share and leading players
Fig. 35 North America market share and leading players
Fig. 36 Europe market share and leading players
Fig. 37 Asia Pacific market share and leading players
Fig. 38 Latin America market share and leading players
Fig. 39 Middle East & Africa market share and leading players
Fig. 40 North America, by country
Fig. 41 North America
Fig. 42 North America market estimates and forecasts, 2018 - 2030
Fig. 43 U.S. key country dynamics
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
Fig. 45 Canada key country dynamics
Fig. 46 Canada market estimates and forecasts, 2018 - 2030
Fig. 47 Mexico key country dynamics
Fig. 48 Mexico market estimates and forecasts, 2018 - 2030
Fig. 49 Europe
Fig. 50 Europe market estimates and forecasts, 2018 - 2030
Fig. 51 UK key country dynamics
Fig. 52 UK market estimates and forecasts, 2018 - 2030
Fig. 53 Germany key country dynamics
Fig. 54 Germany market estimates and forecasts, 2018 - 2030
Fig. 55 France key country dynamics
Fig. 56 France market estimates and forecasts, 2018 - 2030
Fig. 57 Italy key country dynamics
Fig. 58 Italy market estimates and forecasts, 2018 - 2030
Fig. 59 Spain key country dynamics
Fig. 60 Spain market estimates and forecasts, 2018 - 2030
Fig. 61 Denmark key country dynamics
Fig. 62 Denmark market estimates and forecasts, 2018 - 2030
Fig. 63 Sweden key country dynamics
Fig. 64 Sweden market estimates and forecasts, 2018 - 2030
Fig. 65 Norway key country dynamics
Fig. 66 Norway market estimates and forecasts, 2018 - 2030
Fig. 67 Asia Pacific
Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 69 China key country dynamics
Fig. 70 China market estimates and forecasts, 2018 - 2030
Fig. 71 Japan key country dynamics
Fig. 72 Japan market estimates and forecasts, 2018 - 2030
Fig. 73 India key country dynamics
Fig. 74 India market estimates and forecasts, 2018 - 2030
Fig. 75 Australia key country dynamics
Fig. 76 Australia market estimates and forecasts, 2018 - 2030
Fig. 77 South Korea key country dynamics
Fig. 78 South Korea market estimates and forecasts, 2018 - 2030
Fig. 79 Thailand key country dynamics
Fig. 80 Thailand market estimates and forecasts, 2018 - 2030
Fig. 81 Latin America
Fig. 82 Latin America market estimates and forecasts, 2018 - 2030
Fig. 83 Brazil key country dynamics
Fig. 84 Brazil market estimates and forecasts, 2018 - 2030
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina market estimates and forecasts, 2018 - 2030
Fig. 87 Middle East and Africa
Fig. 88 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 89 South Africa key country dynamics
Fig. 90 South Africa market estimates and forecasts, 2018 - 2030
Fig. 91 Saudi Arabia key country dynamics
Fig. 92 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 93 UAE key country dynamics
Fig. 94 UAE market estimates and forecasts, 2018 - 2030
Fig. 95 Kuwait key country dynamics
Fig. 96 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 97 Market share of key market players- Epilepsy monitoring devices market